Positive Impact appoints business development manager
Tony Whyatt brings his experience from Bausch + Lomb and Thea Pharmaceuticals to the Positive Impact team
Positive Impact has appointed a new business development manager to lead on developing the company’s dry eye portfolio and expand its contract sales and training business.
The new appointment, Tony Whyatt, has national account management experience with Bausch + Lomb and Thea Pharmaceuticals.
Managing director of Positive Impact, Maxine Green, said: “My co-director Nick Atkins and I first worked with Tony when we were at Bausch + Lomb and so it’s wonderful to be able to team up with a colleague and friend who has great industry knowledge and experience. I know he will be a great asset to the Positive Impact business portfolio.”
Mr Whyatt added that he is “delighted” to be working with Ms Green and Mr Atkins again and to be given the opportunity to “take their business to the next level.”